10672 results for 'mycoplasma detection kit'

Tocilizumab reverses cytokine release syndrome within hours, and it never touches the cell that started it. That sentence contains the whole mechanism. The trigger is a T cell — engaged by a CAR, a b

Epigenetic Antibodies | 81+ Histone Acetylation & Methylation Antibodies | Assay Genie

Valider en labo vos anticorps pour western blot : testez 2–3 dilutions Pour un Western blot fiable, choisissez un anticorps validé sur des lysats biologiques pertinents, plutôt qu’un anticorps choisi

Inter-Assay vs. Intra-Assay: Präzision richtig berechnen Intra-Assay-Präzision misst, wie stark Duplikate innerhalb eines einzigen Laufs streuen. Inter-Assay-Präzision misst die Schwankung zwischen m

Protein Glycosylation for Labs: Mechanisms, Workflows, and Reagent Tips Protein glycosylation is the enzymatic covalent attachment of sugar chains (glycans) to specific amino acid side chains, most co

Utilisez une coloration protéine totale, comme le Ponceau S, quand vos traitements risquent de faire varier l’expression des protéines de ménage. Sinon, une protéine housekeeping validée pour votr

Cytokine-Storm-Panel: Analyten, Auswahl und Interpretation Ein Cytokine-Storm-Panel ist ein vorvalidiertes Multiplex-Assay, das aus einem einzigen Probenaliquot mehrere pro- und antiinflammatorische

Mouse Multiplex ELISA & Cytokine Assay Panels | Assay Genie

Almost all of the TGF-β in a tissue is already there, and almost none of it is active. That single fact reorganises how the pathway should be studied. Unlike most cytokines, TGF-β is deposited into t

Rat Multiplex ELISA & Cytokine Assay Panels | Assay Genie

PD-1 gets the attention, but it is one brake among many — and the others do not work the same way. The co-inhibitory receptors are routinely drawn as interchangeable stop signs on a T cell. They are

Évitez la rupture de réactifs en 6 actions pour gestionnaires labo Pour éviter la majorité des ruptures de réactifs, auditez votre inventaire critique, fixez des seuils de commande calculés sur le dé

Sofort anwendbar: Probenverdünnung berechnen für Laborpraxis Die Verdünnung berechnen Sie mit der Formel C1·V1 = C2·V2. Meist suchen Sie V1, also das Volumen der Ausgangslösung: V1 = (C2·V2)/C1. Wich

Both interferon families run through STAT1, and that single shared subunit is why they are so often conflated — and why conflating them is a mistake. Type I interferon assembles STAT1 into a three-pa

A T cell does not choose which tissue to defend. The tissue chose it, during priming. A naive T cell has no tropism at all; it acquires one from the dendritic cell that activates it, and the instruct

Neuroscience · Glial CellsOligodendrocytes: Myelination, Lineage Markers and DiseaseOligodendrocytes are the myelinating glia of the central nervous system. A single oligodendrocyte can wrap segments

In most solid tumours the largest immune population is not a T cell. It is a myeloid cell that has been recruited, expanded and re-educated by the tumour itself. Tumour-associated macrophages and mye

Estabilidad de anticuerpos: métodos, criterios y errores de interpretación La estabilidad de anticuerpos se confirma cruzando dos evidencias, nunca una sola: integridad físico-química (temperatura de

ELISA-Platten beschichten: Protokoll, Puffer und Fehlerquellen ELISA-Platten beschichten bedeutet, Antikörper oder Antigene passiv auf Polystyrol-Wells zu immobilisieren, um eine reproduzierbare Bind

Custom In Vivo Antibody Service | Assay Genie

TMB-Substrat im ELISA: Chemie, Protokoll und Fehlerquellen TMB ist das Standardchromogen für HRP-ELISA und liefert nach Oxidation ein blaues Reaktionsprodukt, das sich nach dem Säurestopp bei 450 nm

Harnessing Immune-Checkpoint Inhibition for Cancer Prevention Immune-checkpoint inhibition (ICI) has emerged as a pivotal strategy in cancer therapy, particularly in the context of tu

Understanding the EGFR Pathway and YAP in Non-Small Cell Lung CancerThe epidermal growth factor receptor (EGFR) pathway plays a pivotal role in the development and progression of non-small cell lung c

Variabilité inter-lots des anticorps : l’impact réel sur vos dosages Oui, la variabilité inter-lots d’anticorps est un risque opérationnel concret, pas une hypothèse théorique : elle peut décaler une

Lot-zu-Lot-Variabilität: Wann Sie neue Chargen wirklich prüfen müssen Ja, Lot-zu-Lot-Variabilität ist ein reales analytisches Risiko und keine theoretische Fußnote in einem Qualitätshandbuch. Prüfen

Imagine a specialized squad of immune cells, meticulously trained and equipped, not just to fight cancer, but to sniff it out by its unique metabolic scent. This isn't science fiction; it's the groun

Understanding the Bcl-2 Pathway: Implications for Cancer Therapy The Bcl-2 family of proteins plays a pivotal role in regulating apoptosis, a crucial process for maintaining cellular

Tiempo de entrega de reactivos en Estados Unidos: qué esperar En Estados Unidos, un pedido de reactivo en stock suele llegar en 2 a 5 días hábiles, y ese plazo se alarga si el producto necesita caden

A natural killer cell decides by subtraction. It carries no rearranged antigen receptor and no memory of what it has seen. It presses a panel of germline-encoded receptors against a target and integr

Quick Facts About OnvatilimabWhat is Onvatilimab?Onvatilimab is a monoclonal antibody targeting CD47, often referred to as the "don't eat me" signal, which is overexpressed on many cance

Understanding Lag-3, Tim-3, and TIGIT: Key Players in T Cell RegulationThe immune system's ability to regulate T cell responses is crucial for maintaining homeostasis and combating diseases such as ca

HER2 has no ligand. HER3 has no kinase. Together they are the most potent signalling pair in human biology. That single sentence explains most of what is strange about this receptor family and all of

Techniciens/chercheurs : choisir plaque ELISA selon liaison et optique Pour la plupart des ELISA colorimétriques, choisissez une plaque en polystyrène claire à surface de liaison moyenne ou élevée se

Quick Facts About TinurilimabWhat is Tinurilimab?Tinurilimab is a monoclonal antibody targeting CD47, a protein that cancer cells use to evade immune system attack. By blocking CD47, Tin

Announcement · Powered by Assay GenieIntroducing BioSymposia: The Gathering Place for ScienceWe’re excited to announce the launch of BioSymposia, our new sister platform and a free home for scientific

An agonist antibody does not activate its receptor. It gets held still by something else, and the receptors underneath cluster because they are crowded. That sentence sounds like a technicality and i

The most abundant immunosuppressive molecule in a solid tumour is not a protein. It is adenosine — a metabolite, produced from ATP in two enzymatic steps, at concentrations orders of magnitude above

What You Need to Know About LusvertikimabWhat is Lusvertikimab?Lusvertikimab is a monoclonal antibody designed to inhibit the IL-4 receptor, a key player in regulating immune responses,

Imagine a future where chronic autoimmune diseases, once managed by powerful pharmaceuticals with challenging side effects, are instead calmed by a gentle electrical pulse. This isn't science fiction

Para recuperar la actividad biológica de proteínas recombinantes expresadas como cuerpos de inclusión, la vía más fiable combina una solubilización controlada con un replegamiento gradual, mediant

In the periphery, co-stimulation rescues a T cell. In the thymus, the same molecules kill it. A peripheral T cell that engages its receptor without CD80 and CD86 becomes anergic; engage them and it r

Not one immune cytokine on this pathway touches bone. TNF, IL-1β, IL-6 and IL-17A all act on osteoblasts, osteocytes and synovial fibroblasts, and it is those stromal cells that decide between RANKL

What You Need to Know About CabiralizumabWhat is Cabiralizumab?Cabiralizumab is a monoclonal antibody targeting the colony-stimulating factor-1 receptor (CSF1R), developed for treating c

Quick Facts About UlocuplumabWhat is Ulocuplumab?Ulocuplumab is an investigational monoclonal antibody targeting CXCR4, a chemokine receptor involved in tumor progression and immune cell

Quick Facts About DurvalumabWhat is Durvalumab?Durvalumab (Imfinzi) is a PD-L1 checkpoint inhibitor used in immunotherapy to treat various cancers, including non-small cell lung cancer (

For decades, the fight against cancer has been a relentless battle of attrition, often with treatments that harm the body as much as the disease. But a new era of precision medicine is dawning, one th

Quick Facts About LirilumabWhat is Lirilumab?Lirilumab is an anti-KIR monoclonal antibody designed to enhance natural killer (NK) cell activity by blocking killer-cell immunoglobulin-lik

Quick Info Section: Key Facts About CevostamabWhat is Cevostamab?Cevostamab is an investigational monoclonal antibody targeting CD47, a cell surface protein that helps cancer cells evade

What You Need to Know About BermekimabWhat is Bermekimab?Bermekimab is a monoclonal antibody targeting the CD47 receptor, developed to modulate the immune system and improve conditions l

Anti-angiogenic therapy does not work by starving tumours, and the trials that assumed it did are the reason the field spent a decade disappointed. Cutting off the blood supply was the original pitch

Blocking TNF cures rheumatoid arthritis in some patients and triggers demyelination in others. That is not a dosing problem, and it is not a patient-selection problem. It is the direct consequence of

An antibody–drug conjugate is not a targeted drug. It is a delivery problem with an antibody bolted to the front of it. Binding is the easy part, and it is almost never the part that fails. What deci

Der richtige Startpunkt für die meisten ELISA‑Protokolle ist Magermilchpulver (NFDM) in TBST für HRP‑basierte Assays ohne Phospho‑Ziele, typischerweise in der gängigen Konzentrationsspanne. Bei St

Two drugs aimed at the same axis can give opposite results in the same disease. Blocking IL-23p19 is highly effective in psoriasis and works in Crohn’s disease. Blocking IL-17A directly is highly eff